2018
DOI: 10.1183/13993003.02219-2017
|View full text |Cite
|
Sign up to set email alerts
|

Inhaler adherence in severe asthma: is there an electronic solution?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…36 The design and validation of the device have been previously published. 22,46 What's known • Problems of poor adherence and IT are historically reported in the literature among respiratory patients, with no signs of substantial improvement. 22,46 What's known • Problems of poor adherence and IT are historically reported in the literature among respiratory patients, with no signs of substantial improvement.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…36 The design and validation of the device have been previously published. 22,46 What's known • Problems of poor adherence and IT are historically reported in the literature among respiratory patients, with no signs of substantial improvement. 22,46 What's known • Problems of poor adherence and IT are historically reported in the literature among respiratory patients, with no signs of substantial improvement.…”
Section: Introductionmentioning
confidence: 99%
“…29,36,37,[42][43][44][45] The device is certified (EU registered) 30 and has Food and Drug Administration (FDA) approval. 22,46 What's known • Problems of poor adherence and IT are historically reported in the literature among respiratory patients, with no signs of substantial improvement.…”
Section: Introductionmentioning
confidence: 99%
“…Adherence assessment is complex and we feel that F ENO suppression alone should not preclude treatment with biologics [11]. Newer technologies, including digital inhaler devices [12], may enhance adherence assessment and enable F ENO suppression testing to be undertaken remotely.…”
mentioning
confidence: 99%
“…A comprehensive review of systematic reviews was conducted that captured a large number of outcomes, including cost effectiveness [12]. However, this review was published in 2014, and given the rapid evolution of digital technology [16], the state of the field has changed since the review was conducted; for instance, electronic inhaler monitoring is a relatively new development [17,18], with smart inhalers only recently becoming commercially available [19]. Unni et al's review [9] did analyse studies of children and adults separately, but only 16 studies concerning children were included.…”
Section: Rationalementioning
confidence: 99%